NASDAQ · Biotechnology

ATAI Life Sciences BV (ATAI)

$7.38 -0.54%

Add alert

73 Overbought Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 200$4.46+65.47%

Company profile

ATAI Life Sciences is a pharmaceutical company that is developing psychedelics, other hallucinogens, entactogens, and related drugs for treatment of psychiatric conditions. It was founded in 2018 and is headquartered in Berlin, Germany.

SectorHealthcare

IndustryBiotechnology

Market cap$2.68B

P/E ratioNone

EPS$-2.85

Beta1.553

Dividend yield0.00%

52-week high$7.26

52-week low$3.27

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 79 VRTX Vertex Pharmaceuticals Inc RSI 67 CRSP CRISPR Therapeutics AG RSI 67 IOVA Iovance Biotherapeutics Inc RSI 72 MRNA Moderna Inc RSI 72 VKTX Viking Therapeutics Inc RSI 48 SRPT Sarepta Therapeutics Inc RSI 59 EDIT Editas Medicine Inc RSI 57 NVAX Novavax Inc RSI 63 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 46

Free forever

RSI alerts for ATAI

Get an email the moment ATAI Life Sciences BV crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 14 August 2026 at 8:18 AM EDT